NM_001503.4(GPLD1):c.1844G>A (p.Arg615Gln) AND not specified

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 31, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004073705.1

Allele description [Variation Report for NM_001503.4(GPLD1):c.1844G>A (p.Arg615Gln)]

NM_001503.4(GPLD1):c.1844G>A (p.Arg615Gln)

Gene:

GPLD1:glycosylphosphatidylinositol specific phospholipase D1 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

6p22.3

Genomic location:

Preferred name:

NM_001503.4(GPLD1):c.1844G>A (p.Arg615Gln)

HGVS:

NC_000006.12:g.24445808C>T
NG_029888.2:g.48815G>A
NM_001503.4:c.1844G>AMANE SELECT
NP_001494.2:p.Arg615Gln
NC_000006.11:g.24446036C>T
NM_001503.2:c.1844G>A

Protein change:

R615Q

Molecular consequence:

NM_001503.4:c.1844G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: AllHighlyPenetrant
Identifiers:: MedGen: CN169374

Recent activity

Clear Turn Off Turn On

SAMN04155487 (2)
SRA
Psoralea glabra voucher Muasya3646 trnL-trnF intergenic spacer region, partial s...
Psoralea glabra voucher Muasya3646 trnL-trnF intergenic spacer region, partial sequence; chloroplast
gi|2675378064|gb|PP318964.1|

Nucleotide
RPL39P30 ribosomal protein L39 pseudogene 30 [Homo sapiens]
RPL39P30 ribosomal protein L39 pseudogene 30 [Homo sapiens]
Gene ID:100271519

Gene
LOC129931640 [Homo sapiens]
LOC129931640 [Homo sapiens]
Gene ID:129931640

Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003535402	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Jan 31, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003535402

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Jan 31, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003535402.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The c.1844G>A (p.R615Q) alteration is located in exon 19 (coding exon 19) of the GPLD1 gene. This alteration results from a G to A substitution at nucleotide position 1844, causing the arginine (R) at amino acid position 615 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 10, 2024

ClinVar

Relating variation to medicine